ABSTRACT
AIMS AND OBJECTIVES
To evaluate whether there is role of Ginkgo biloba
in treatment of tinnitus or not, using Tinnitus
Handicap Inventory
MATERIAL METHODS: The present prospective
study, after approval by Institutional Ethics
Committee, was conducted in Department of
ENT, GMC Jammu from January 2019 to January
2020 on 90 patients with primary complaint of
tinnitus. Inclusion criteria- Age: 20 years or above,
Duration of tinnitus > 3 months. Informed consent
was taken and all patients were asked to
complete the THI-Tinnitus Handicap Inventory. All
patients were given 50mg of Ginkgo biloba
standardized extract LI 1370 (containing 25%
flavonoids, 3% ginkgolides and 5% bilobalides).
Patients were advised to take three tablets daily
for 12 weeks.
RESULTS
The mean pre-treatment THI score was 43.6 and
mean post-treatment THI score (at 12 weeks) was
39.4; the mean change in THI score was 4.2, the
result being statistically insignificant (p-value=
0.43). Out of 90 patients, 51 reported unchanged
severity of tinnitus, 27 patients reported
improvement in severity of tinnitus and 12 patients
reported worsening of condition.
CONCLUSION
According to our study, Ginkgo biloba has no
significant therapeutic role in tinnitus. However,
the aetiology of tinnitus is multifactorial and
Ginkgo biloba could benefit patients with
ischemic aetiology.
KEYWORDS
Ginkgo, biloba, handicap, inventory, tinnitus